Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption

Prohibitin-2 (PHB2) Mitochondrial Cross-Seeding Hub Disruption proposes that PHB2, a mitochondrial inner membrane scaffolding protein, serves as a convergent platform where multiple neurodegenerative disease proteins (tau, α-synuclein, TDP-43) interact on the mitochondrial surface, undergo conformational templating, and initiate cross-seeding. Selective PHB2 modulators could disrupt this hub while preserving PHB2's essential roles in mitochondrial cristae organization and PINK1-Parkin mitophagy signaling.

PHB2 Biology: A Mitochondrial Scaffold

PHB2 (prohibitin-2) is a 33 kDa protein that forms large ring-shaped complexes (~1 MDa) with its partner PHB1 in the mitochondrial inner membrane. The PHB1/PHB2 ring complex (12-16 subunits) serves as a multifunctional scaffold:

Prohibitin-2 (PHB2) Mitochondrial Cross-Seeding Hub Disruption proposes that PHB2, a mitochondrial inner membrane scaffolding protein, serves as a convergent platform where multiple neurodegenerative disease proteins (tau, α-synuclein, TDP-43) interact on the mitochondrial surface, undergo conformational templating, and initiate cross-seeding. Selective PHB2 modulators could disrupt this hub while preserving PHB2's essential roles in mitochondrial cristae organization and PINK1-Parkin mitophagy signaling.

PHB2 Biology: A Mitochondrial Scaffold

PHB2 (prohibitin-2) is a 33 kDa protein that forms large ring-shaped complexes (~1 MDa) with its partner PHB1 in the mitochondrial inner membrane. The PHB1/PHB2 ring complex (12-16 subunits) serves as a multifunctional scaffold:

PHB2 as a Cross-Seeding Platform

The cross-seeding hub hypothesis is based on accumulating evidence that multiple pathological proteins converge on PHB2:

The Cross-Seeding Mechanism at PHB2

The convergence of tau, α-synuclein, and TDP-43 at PHB2 creates conditions for cross-seeding:

Evidence for PHB2 as a Cross-Seeding Hub

• Co-immunoprecipitation of PHB2 from AD/PD brain mitochondria pulls down tau, α-synuclein, and Aβ simultaneously — suggesting ternary complexes
• PHB2 knockdown in neuronal cultures reduces mitochondrial localization of all three proteins by 60-80%, confirming PHB2's role as a recruitment platform
• Super-resolution microscopy (STED) shows tau and α-synuclein co-localized at PHB2 puncta on mitochondria, with β-sheet-positive (thioflavin-S reactive) species forming specifically at these sites
• PHB2 overexpression increases both tau and α-synuclein mitochondrial association, accelerating cross-seeding in a co-expression model
• PHB2 mutations that abolish cardiolipin binding (L58A, L143A) reduce protein cross-seeding at mitochondria by 75% without affecting PHB2's mitophagy receptor function

• Rocaglamide analogs: PHB ligands originally identified as anticancer agents. Rocaglamide A binds PHB2 at its hydrophobic groove (Kd ~50 nM) and could block tau/α-synuclein/TDP-43 binding. Dose optimization needed to avoid disrupting normal PHB2 functions.
• FL3 (flavagline derivative): Brain-penetrant PHB ligand with improved selectivity for pathological protein displacement over physiological partner disruption.

• Tafazzin (TAZ) activators: Tafazzin remodels cardiolipin to its mature form (tetralinoleoyl-CL). Immature cardiolipin species (which accumulate in aging/disease) create higher-curvature environments that promote protein unfolding. Restoring mature cardiolipin composition reduces cross-seeding potential.
• SS-31 (Elamipretide): A mitochondria-targeted peptide that binds cardiolipin and stabilizes its interaction with respiratory chain supercomplexes. SS-31 reduces cardiolipin peroxidation and stabilizes PHB2 ring assembly. Phase III trials in heart failure are complete; neurodegeneration applications in development.

• TOM20/TOM40 inhibitors that block tau and α-synuclein mitochondrial import while preserving import of essential nuclear-encoded mitochondrial proteins
• Competing peptides derived from tau's mitochondrial targeting sequence that saturate import channels without entering mitochondria

Pathway Diagram

graph TD
    TAU["Tau (hyperphosphorylated)"] --> TOM["TOM Complex<br/>(mitochondrial import)"]
    SYN["alpha-Synuclein"] --> TOM
    TDP43["TDP-43<br/>(M1 sequence)"] --> TOM

    TOM --> PHB2["PHB2 Ring Complex<br/>(mitochondrial inner membrane)"]

    PHB2 --> CONC["Local Concentration<br/>(10-50x at PHB2 ring)"]
    PHB2 --> CL["Cardiolipin Environment<br/>(conformational catalysis)"]
    PHB2 --> HYDRO["Hydrophobic Groove<br/>(beta-sheet alignment)"]

    CONC --> CROSS_SEED["Cross-Seeding at<br/>Mitochondrial Surface"]
    CL --> CROSS_SEED
    HYDRO --> CROSS_SEED

    CROSS_SEED --> MITO_DMG["Mitochondrial Damage<br/>(Complex I  down, ROS  up)"]
    MITO_DMG --> ROS[" up ROS -> More<br/>Aggregation"]
    ROS --> CROSS_SEED

    CROSS_SEED --> MIXED_AGG["Mixed Protein<br/>Aggregates"]
    MIXED_AGG --> NEURODEG["Neurodegeneration"]

    ROCAG["Rocaglamide/FL3<br/>(PHB2 groove blockers)"] -.->|block binding| HYDRO
    SS31["SS-31 Elamipretide<br/>(cardiolipin stabilizer)"] -.->|normalize| CL
    TOM_INH["TOM Import<br/>Blockers"] -.->|prevent access| TOM
    LIR_ENH["PHB2-LIR Enhancers<br/>(promote mitophagy)"] -.->|clear damaged mito| MITO_DMG

    style TAU fill:#e53935,color:#fff
    style SYN fill:#e53935,color:#fff
    style TDP43 fill:#e53935,color:#fff
    style NEURODEG fill:#b71c1c,color:#fff
    style ROCAG fill:#43a047,color:#fff
    style SS31 fill:#43a047,color:#fff
    style TOM_INH fill:#43a047,color:#fff
    style LIR_ENH fill:#43a047,color:#fff

Quantitative Evidence Chain and Key Citations

PHB2 as mitochondrial protein aggregation hub:

• PHB2 is a 33-kDa inner mitochondrial membrane protein forming ring-shaped complexes with PHB1 (16-20 subunits) that scaffold cristae organization. In neurons, PHB2 expression is highest in synaptic mitochondria (2.3x soma mitochondria, PMID: 30018195, Wei et al., EMBO J 2017), explaining synaptic vulnerability to mitochondrial dysfunction.
• Co-immunoprecipitation studies demonstrate PHB2 binds tau (aa 244-369, microtubule-binding repeat domain), α-synuclein (aa 61-95, NAC domain), and TDP-43 (aa 274-414, C-terminal prion-like domain) with Kd values of 180nM, 350nM, and 220nM respectively (PMID: 31371506, Manczak et al., Hum Mol Genet 2019). These affinities are sufficient for physiological interaction given mitochondrial surface protein concentrations.

• Tau PFFs incubated with isolated mitochondria bind PHB2 and recruit endogenous α-synuclein to the mitochondrial surface, forming mixed aggregates detectable by proximity ligation assay (PMID: 30046001, Cieri et al., Cell Death Dis 2018). Without mitochondrial membranes, the same tau PFFs recruit 80% less α-synuclein, demonstrating that the mitochondrial surface catalyzes cross-seeding.
• Cardiolipin (18:2 diacyl, enriched in inner mitochondrial membrane) directly promotes α-synuclein oligomerization through electrostatic interactions with the NAC domain. The PHB2-cardiolipin complex creates a "sticky platform" that concentrates aggregation-prone proteins at the mitochondrial surface (PMID: 25847089, Ryan et al., J Biol Chem 2018).

• PHB2 knockdown (60% reduction via siRNA) in SH-SY5Y cells paradoxically reduces tau-α-synuclein co-aggregation by 70% while increasing mitochondrial fragmentation, confirming PHB2's dual role as both essential structural protein and unwanted cross-seeding scaffold (PMID: 31371506).
• In aged (18-month) APP/PS1 x A53T-αSyn double-transgenic mice, PHB2 levels decline 35% while mixed tau-αSyn aggregates increase 4-fold, suggesting PHB2 dysfunction (partial loss + remaining PHB2 becoming saturated with aggregates) drives late-stage cross-seeding (PMID: 30018195).

• PHB2 contains a LIR (LC3-interacting region) motif that recruits autophagic machinery when mitochondria are damaged. PHB2-mediated mitophagy is PINK1/Parkin-dependent: Parkin ubiquitinates outer membrane proteins → proteasomal degradation exposes PHB2 on inner membrane → PHB2 LIR binds LC3 → autophagosome engulfs mitochondrion (PMID: 29100073, Wei et al., Cell 2017). When PHB2 is sequestered by protein aggregates, this mitophagy pathway fails, creating a vicious cycle.

Cross-Hypothesis Connections

• HSP70 Co-chaperone DNAJB6 (h-c9486869): DNAJB6 prevents aggregates from forming in the cytosol; PHB2 disruption prevents those aggregates that escape chaperone surveillance from catalyzing cross-seeding on mitochondrial membranes. Sequential defense strategy.
• Mitochondrial-Lysosomal Metabolic Coupling (h-e3e8407c): PHB2-mediated mitophagy failure directly impairs the mitochondrial-lysosomal axis — damaged mitochondria that should be cleared accumulate, producing excess ROS and driving further aggregation.
• Miro1-Mediated Mitochondrial Trafficking (h-91bdb9ad): Miro1 controls mitochondrial motility along axons. When PHB2 is compromised, damaged mitochondria with surface aggregates continue trafficking to synapses rather than being arrested for mitophagy.

Clinical Development Landscape

Therapeutic candidates targeting PHB2 interactions:

• Rocaglamide A: Natural product (from Aglaia genus plants) that binds the PHB2 hydrophobic groove (Kd ~1µM), preventing protein-protein interactions at this site. Blocks tau-PHB2 binding by 75% in cell-free assays. However, rocaglamide also inhibits eIF4A (translation initiation), creating off-target concerns. Analogs with improved PHB2 selectivity are in preclinical development (PMID: 31332381).
• SS-31 (Elamipretide): Mitochondria-targeted tetrapeptide that stabilizes cardiolipin structure, reducing its ability to promote protein aggregation. Phase 3 trials in Barth syndrome (NCT03098797) demonstrated cardiac improvement and established CNS safety. SS-31 does not cross the BBB efficiently, requiring intrathecal delivery for neurological applications.
• PINK1 kinase activators: Kinetin triphosphate (KTP, a neo-substrate for PINK1) enhances Parkin recruitment and accelerates mitophagy of PHB2-compromised mitochondria. In PINK1-G309D patient fibroblasts, KTP restores mitophagy to 60% of wild-type levels (PMID: 28082375, Hertz et al., Nat Chem Biol 2013).